MC4000

Wheelchair accessiblewide entryADA-friendly design

Description on file

Stored directory description. It is not a test we ran of this chamber.

The MC4000 is Macy-Pan's wheelchair-accessible hyperbaric chamber, featuring a wide entry that allows wheelchair users to roll directly into the chamber. Operating at 1.3-1.4 ATA, it makes mild hyperbaric therapy accessible to mobility-impaired individuals. Suitable for ADA-compliant clinical settings.

Who is this for?

Engineered from the ground up for accessibility — wheelchair users, mobility-impaired patients, and ADA-compliant clinics can use the MC4000 without needing workarounds. The accessible entry design removes one of the most significant barriers to hyperbaric therapy for patients with limited mobility, making it an essential choice for rehab centers and inclusive wellness facilities. If ADA compliance is a requirement or a genuine priority, this is one of the few chambers designed with that as a primary specification.

Who it suits

MC4000 is a soft-shell chamber, listed at 1.3 ATA, in the $10,000–$25,000 listed-price band, with a listed capacity of 1-person + wheelchair, listed interior size Wheelchair-accessible entry.

The listing describes who it is for as: Engineered from the ground up for accessibility — wheelchair users, mobility-impaired patients, and ADA-compliant clinics can use the MC4000 without needing workarounds. The accessible entry design removes one of the most significant barriers to hyperbaric therapy for patients with limited mobility, making it an essential choice for rehab centers and inclusive wellness facilities. If ADA compliance is a requirement or a genuine priority, this is one of the few chambers designed with that as a primary specification.

This is not medical advice. Ask your doctor which pressure and setting fit you, and read the Athletic Recovery & Sports Performance guide.

Who should skip it

Listed maximum pressure is 1.3 ATA. HBOT Finder's chamber guide treats 2.0 ATA as the clinical standard, so this chamber is not for protocols that require 2.0 ATA or higher.
Listed chamber type is soft-shell, so this is not a hard-shell clinical chamber.
FDA clearance in our database is "no", so this is not an FDA-cleared device.
Listed portability is fixed-installation, so this is not a portable chamber.
The low price estimate is $12,400, so this is not a chamber listed under $10,000.

Estimated Price

$12,400

Among 22 soft-shell chambers with a listed low price in the $10,000–$25,000 band, those low prices run from $10,195 to $23,000. This chamber's listed low price is $12,400.

Calculate ownership cost Request a Quote

We reply the same day.

Contact manufacturer

Used for

Based on the protocol pressure and tier this chamber supports. FDA-approved indications marked.

Athletic Recovery & Sports Performance Post-Surgical Recovery Cerebral Palsy Migraine & Cluster Headaches Autism Spectrum Disorder

Closest listed alternatives

Same chamber type and listed-price band. Sorted by how close the listed low price and pressure are.

Chamber	Type	ATA	Listed price	Compare
ProReset Flow 80	soft-shell	1.5	Contact manufacturer	—
AHA Vita	soft-shell	1.7	$12,000 - $16,000 (estimated)	Compare
Macy-Pan ST2200	soft-shell	1.4	$11,600 - $13,600	—

Best-of lists

Home chambers under $25,000

Questions from the listing

What maximum pressure is listed for the MC4000?

The MC4000 listing shows a maximum pressure of 1.3 ATA.

What price is listed for the MC4000?

The listing shows $12,400.

Is the MC4000 listed as FDA cleared?

In the HBOT Finder database, FDA clearance for the MC4000 is "no".

What type of chamber is the MC4000?

The MC4000 is listed as a soft-shell chamber.

What size is listed for the MC4000?

The listing gives capacity 1-person + wheelchair and interior dimensions Wheelchair-accessible entry.

Does this page say whether the MC4000 is right for a medical condition?

No. This page only repeats the chamber's listed specifications. Ask your doctor before using hyperbaric oxygen therapy. Condition guides on this site summarize published research and are not personal medical advice.